This brand name is authorized in Nigeria.
The drug METFOSYN contains one active pharmaceutical ingredient (API):
1
|
UNII
786Z46389E - METFORMIN HYDROCHLORIDE
|
Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
B4-6658 | Tablet | METFOSYN TABLET TAB 500 mg 110,1010 | 67 RNW-PP-226005 METFOSYN TABLET METFORMIN TABLETS BP 500MG Metformin Hydrochloride BP 500mg B4-6658 Drugs Imported Products 110,1010 Prescription Only Medicine (POM) 10/27/2022 SYNERMED (NIGERIA) LIMITED, ADENIYI JONES IKEJA LAGOS LAGOS 8035873263 synermednigeria@hotmail.com ZEST PHARMA, PLOT NO.275, SECTOR 'F' SANWAR ROAD, INDORE :- 452015 (M.P), INDIA, India | 06/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
A10BA02 | Metformin | A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BA Biguanides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | B4-6658 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.